142 related articles for article (PubMed ID: 7784261)
1. Homologous regulation of vasoactive intestinal peptide (VIP) receptors on rat peritoneal macrophages.
Pozo D; Guerrero JM; Calvo JR
Peptides; 1995; 16(2):313-8. PubMed ID: 7784261
[TBL] [Abstract][Full Text] [Related]
2. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
3. Stimulatory effect of vasoactive intestinal peptide (VIP) on cyclic AMP production in rat peritoneal macrophages.
Segura JJ; Guerrero JM; Goberna R; Calvo JR
Regul Pept; 1992 Feb; 37(3):195-203. PubMed ID: 1372999
[TBL] [Abstract][Full Text] [Related]
4. Expression of VIP receptors in mouse peritoneal macrophages: functional and molecular characterization.
Calvo JR; Montilla ML; Guerrero JM; Segura JJ
J Neuroimmunol; 1994 Feb; 50(1):85-93. PubMed ID: 8300860
[TBL] [Abstract][Full Text] [Related]
5. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages.
Sakakibara H; Shima K; Said SI
Am J Physiol; 1994 Sep; 267(3 Pt 1):L256-62. PubMed ID: 7943252
[TBL] [Abstract][Full Text] [Related]
6. Effects of PACAP, VIP and related peptides on cyclic AMP formation in rat neuronal and astrocyte cultures and cerebral cortical slices.
Jozwiak-Bebenista M; Dejda A; Nowak JZ
Pharmacol Rep; 2007; 59(4):414-20. PubMed ID: 17901570
[TBL] [Abstract][Full Text] [Related]
7. Characterization of VIP receptor-effector system antagonists in rat and mouse peritoneal macrophages.
Pozo D; Montilla ML; Guerrero JM; Calvo JR
Eur J Pharmacol; 1997 Mar; 321(3):379-86. PubMed ID: 9085051
[TBL] [Abstract][Full Text] [Related]
8. Characterization of functional receptors for vasoactive intestinal peptide (VIP) in rat peritoneal macrophages.
Segura JJ; Guerrero JM; Goberna R; Calvo JR
Regul Pept; 1991 Apr; 33(2):133-43. PubMed ID: 1652777
[TBL] [Abstract][Full Text] [Related]
9. Characterization of VIP-and helodermin-preferring receptors on rat platelets.
Shima K; Sakakibara H; Said SI
Regul Pept; 1996 Jul; 63(2-3):99-103. PubMed ID: 8837217
[TBL] [Abstract][Full Text] [Related]
10. Thymosin alpha 1 interacts with the VIP receptor-effector system in rat and mouse immunocompetent cells.
Pozo D; Guerrero JM; Segura JJ; Calvo JR
Immunopharmacology; 1996 Sep; 34(2-3):113-23. PubMed ID: 8886855
[TBL] [Abstract][Full Text] [Related]
11. Interaction of peptides related to VIP and secretin with guinea pig pancreatic acini.
Zhou ZC; Gardner JD; Jensen RT
Am J Physiol; 1989 Feb; 256(2 Pt 1):G283-90. PubMed ID: 2465694
[TBL] [Abstract][Full Text] [Related]
12. Expression of functional receptors for vasoactive intestinal peptide in freshly isolated and cultured gastric muscle cells.
Chijiiwa Y; Murthy KS; Grider JR; Makhlouf GM
Regul Pept; 1993 Sep; 47(3):223-32. PubMed ID: 8234906
[TBL] [Abstract][Full Text] [Related]
13. Secretin and vasoactive intestinal peptide are potent stimulants of cellular contraction and accumulation of cyclic AMP in rat ventricular cardiomyocytes.
Bell D; McDermott BJ
J Cardiovasc Pharmacol; 1994 Jun; 23(6):959-69. PubMed ID: 7523789
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors.
Lundberg P; Lundgren I; Mukohyama H; Lehenkari PP; Horton MA; Lerner UH
Endocrinology; 2001 Jan; 142(1):339-47. PubMed ID: 11145597
[TBL] [Abstract][Full Text] [Related]
15. Homologous regulation of adenylate cyclase-coupled receptors for vasoactive intestinal peptide (VIP) on human mononuclear leucocytes.
Wiik P
Regul Pept; 1988 Apr; 20(4):323-33. PubMed ID: 2835796
[TBL] [Abstract][Full Text] [Related]
16. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
[TBL] [Abstract][Full Text] [Related]
17. Interaction of thymic peptide thymosin alpha 1 with VIP receptors in rat intestinal epithelial cells: comparison with PHI and secretin.
Calvo JR; Guerrero JM; Goberna R
Gen Pharmacol; 1989; 20(4):503-5. PubMed ID: 2546855
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal polypeptide-related peptides modulate tyrosine hydroxylase gene expression in PC12 cells through multiple adenylate cyclase-coupled receptors.
Wessels-Reiker M; Basiboina R; Howlett AC; Strong R
J Neurochem; 1993 Mar; 60(3):1018-29. PubMed ID: 8094740
[TBL] [Abstract][Full Text] [Related]
19. Receptors for vasoactive intestinal peptide and secretin on guinea pig pancreatic acini.
Zhou ZC; Gardner JD; Jensen RT
Peptides; 1987; 8(4):633-7. PubMed ID: 2819833
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]